Similar articles for PMID: 16940271

Year	Number of Results
1982	1
2000	2
2001	2
2002	2
2003	8
2004	3
2005	10
2006	14
2007	25
2008	11
2009	12
2010	6
2011	1
2012	3
2013	3
2014	6
2015	1
2016	2
2017	1
2018	3
2019	1
2020	2
2021	1
2023	1
2024	0

1

Use of memantine to treat Alzheimer's disease.

Gauthier S, Herrmann N, Ferreri F, Agbokou C. Gauthier S, et al. CMAJ. 2006 Aug 29;175(5):501-2. doi: 10.1503/cmaj.1060168. CMAJ. 2006. PMID: 16940271 Free PMC article. No abstract available.

2

Memantine for Alzheimer's disease.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2003 Sep 15;45(1165):73-4. Med Lett Drugs Ther. 2003. PMID: 12968123 No abstract available.

3

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.

Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P. Waldemar G, et al. Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979. Int J Geriatr Psychiatry. 2008. PMID: 18229874 Clinical Trial. No abstract available.

4

I remember.

Ladouceur R. Ladouceur R. Can Fam Physician. 2006 Feb;52:155. Can Fam Physician. 2006. PMID: 16529383 Free article. English, French. No abstract available.

5

Another perspective on the memantine graphs: clinical vs. statistical significance.

Davis S. Davis S. Med Health R I. 2005 Jan;88(1):12-4; discussion 14. Med Health R I. 2005. PMID: 15779549 No abstract available.

6

[Alzheimer dementia. Memantine: value for patient and caregivers].

[No authors listed] [No authors listed] MMW Fortschr Med. 2009 Nov 5;151(45):44-5. MMW Fortschr Med. 2009. PMID: 19960725 German. No abstract available.

7

The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis.

Livingston G, Katona C. Livingston G, et al. Int J Geriatr Psychiatry. 2004 Oct;19(10):919-25. doi: 10.1002/gps.1166. Int J Geriatr Psychiatry. 2004. PMID: 15449303

8

[Anti-dementia therapy pays at every stage of the disease. Patients with Alzheimer's disease stay all-day fit longer].

[No authors listed] [No authors listed] MMW Fortschr Med. 2003 May 26;145 Suppl 2:113. MMW Fortschr Med. 2003. PMID: 14579507 German. No abstract available.

9

[Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)].

Agüera-Ortiz LF; Grupo de Investigadores del Estudio MEMORY. Agüera-Ortiz LF, et al. Rev Neurol. 2010 Nov 1;51(9):525-34. Rev Neurol. 2010. PMID: 20979032 Clinical Trial. Spanish.

10

[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].

Frölich L, Schmitt B, Calabrese P, Diener H, Förstl H, Gertz HJ, Hallauer JF, Hampel H, Ihl R, Rieke K, Riepe M, Supprian T. Frölich L, et al. Dtsch Med Wochenschr. 2005 Feb 25;130(8):408-12. doi: 10.1055/s-2005-863066. Dtsch Med Wochenschr. 2005. PMID: 15717252 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year